Oxidative stress and nerve damage: role in chemotherapy induced peripheral neuropathy
Aparna Areti, Veera Ganesh Yerra, Vgm Naidu, Ashutosh Kumar, Aparna Areti, Veera Ganesh Yerra, Vgm Naidu, Ashutosh Kumar
Abstract
Peripheral neuropathy is a severe dose limiting toxicity associated with cancer chemotherapy. Ever since it was identified, the clear pathological mechanisms underlying chemotherapy induced peripheral neuropathy (CIPN) remain sparse and considerable involvement of oxidative stress and neuroinflammation has been realized recently. Despite the empirical use of antioxidants in the therapy of CIPN, the oxidative stress mediated neuronal damage in peripheral neuropathy is still debatable. The current review focuses on nerve damage due to oxidative stress and mitochondrial dysfunction as key pathogenic mechanisms involved in CIPN. Oxidative stress as a central mediator of apoptosis, neuroinflammation, metabolic disturbances and bioenergetic failure in neurons has been highlighted in this review along with a summary of research on dietary antioxidants and other nutraceuticals which have undergone prospective controlled clinical trials in patients undergoing chemotherapy.
Keywords: Chemotherapy; Mitochondria; Mitotoxicity; Nutraceuticals; Oxidative stress; Peripheral neuropathy.
Figures
References
- Ferrier J., Pereira V., Busserolles J., Authier N., Balayssac D. Emerging trends in understanding chemotherapy-induced peripheral neuropathy. Current Pain and Headache Reports. 2013;17:364–371.
- Wolf S., Barton D., Kottschade L., Grothey A., Loprinzi C. Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies. Eur. J. Cancer. 2008;44:1507–1515.
- Wang X.-M., Lehky T.J., Brell J.M., Dorsey S.G. Discovering cytokines as targets for chemotherapy-induced painful peripheral neuropathy. Cytokine. 2012;59:3–9.
- Brzezinski K. Chemotherapy-induced polyneuropathy. Part I. Pathophysiology. Contemp. Oncol. (Poznań, Poland) 2012;16:72–80.
- Argyriou A.A., Bruna J., Marmiroli P., Cavaletti G. Chemotherapy-induced peripheral neurotoxicity (CIPN): an update. Crit. Rev. Oncol./Hematol. 2012;82:51–77.
- Conklin K.A. Chemotherapy-associated oxidative stress: impact on chemotherapeutic effectiveness. Integr. Cancer Ther. 2004;3:294–300.
- Low P.A., Nickander K.K., Tritschler H.J. The roles of oxidative stress and antioxidant treatment in experimental diabetic neuropathy. Diabetes. 1997;46:S38–S42.
- Xiao W.H., Bennett G.J. Effects of mitochondrial poisons on the neuropathic pain produced by the chemotherapeutic agents, paclitaxel and oxaliplatin. Pain. 2012;153:704–709.
- Negi G., Kumar A., Joshi R.P., Sharma S.S. Oxidative stress and Nrf2 in the pathophysiology of diabetic neuropathy: old perspective with a new angle. Biochem. Biophys. Res. Commun. 2011;408:1–5.
- Negi G., Kumar A., Sharma S.S. Melatonin modulates neuroinflammation and oxidative stress in experimental diabetic neuropathy: effects on NF-kB and Nrf2 cascades. J. Pineal Res. 2011;50:124–131.
- Prasad S.N., Muralidhara Neuroprotective effect of geraniol and curcumin in an acrylamide model of neurotoxicity in Drosophila melanogaster: relevance to neuropathy. J. Insect Physiol. 2013;60:7–16.
- Saifi G.M., Szigeti K., Snipes G.J., Garcia C.A., Lupski J.R. Molecular mechanisms, diagnosis, and rational approaches to management of and therapy for Charcot–Marie–Tooth disease and related peripheral neuropathies. J. Investig. Med.: Off. Publ. Am. Fed. Clin. Res. 2003;51:261–283.
- McDonald E.S., Windebank A.J. Cisplatin-induced apoptosis of DRG neurons involves bax redistribution and cytochrome c release but not fas receptor signaling. Neurobiol. Dis. 2002;9:220–233.
- Salvemini D., Little J.W., Doyle T., Neumann W.L. Roles of reactive oxygen and nitrogen species in pain. Free Radic. Biol. Med. 2011;51:951–966.
- Ta L.E., Schmelzer J.D., Bieber A.J., Loprinzi C.L., Sieck G.C., Brederson J.D., Low P.A., Windebank A.J. A novel and selective poly (ADP-ribose) polymerase inhibitor ameliorates chemotherapy-induced painful neuropathy. PloS One. 2013;8:e54161.
- Ganesh Yerra V., Negi G., Sharma S.S., Kumar A. Potential therapeutic effects of the simultaneous targeting of the Nrf2 and NF-kB pathways in diabetic neuropathy. Redox Biol. 2013;1:394–397.
- Negi G., Kumar A., Sharma S. S. Nrf2 and NF-kB modulation by sulforaphane counteracts multiple manifestations of diabetic neuropathy in rats and high glucose-induced changes. Curr. Neurovasc. Res. 2011;8:294–304.
- Lupachyk S., Shevalye H., Maksimchyk Y., Drel V.R., Obrosova I.G. PARP inhibition alleviates diabetes-induced systemic oxidative stress and neural tissue 4-hydroxynonenal adduct accumulation: correlation with peripheral nerve function. Free Radic. Biol. Med. 2011;50:1400–1409.
- Negi G., Kumar A., Sharma S.S. Concurrent targeting of nitrosative stress & PARP pathway corrects functional, behavioral and biochemical deficits in experimental diabetic neuropathy. Biochem. Biophys. Res. Commun. 2010;391:102–106.
- Janes K., Doyle T., Bryant L., Esposito E., Cuzzocrea S., Ryerse J., Bennett G.J., Salvemini D. Bioenergetic deficits in peripheral nerve sensory axons during chemotherapy-induced neuropathic pain resulting from peroxynitrite-mediated post-translational nitration of mitochondrial superoxide dismutase. Pain. 2013;154:2432–2440.
- Jin H.W., Flatters S.J.L., Xiao W.H., Mulhern H.L., Bennett G.J. Prevention of paclitaxel-evoked painful peripheral neuropathy by acetyl-L-carnitine: effects on axonal mitochondria, sensory nerve fiber terminal arbors, and cutaneous Langerhans cells. Exp. Neurol. 2008;210:229–237.
- Podratz J.L., Knight A.M., Ta L.E., Staff N.P., Gass J.M., Genelin K., Schlattau A., Lathroum L., Windebank A.J. Cisplatin induced mitochondrial DNA damage in dorsal root ganglion neurons. Neurobiol. Dis. 2011;41:661–668.
- Zheng H., Xiao W.H., Bennett G.J. Mitotoxicity and bortezomib-induced chronic painful peripheral neuropathy. Exp. Neurol. 2012;238:225–234.
- Zheng H., Xiao W.H., Bennett G.J. Functional deficits in peripheral nerve mitochondria in rats with paclitaxel-and oxaliplatin-evoked painful peripheral neuropathy. Exp. Neurol. 2011;232:154–161.
- Xiao W.H., Zheng H., Zheng F.Y., Nuydens R., Meert T.F., Bennett G.J. Mitochondrial abnormality in sensory, but not motor, axons in paclitaxel-evoked painful peripheral neuropathy in the rat. Neuroscience. 2011;199:461–469.
- Flatters S.J.L., Bennett G.J. Studies of peripheral sensory nerves in paclitaxel-induced painful peripheral neuropathy: evidence for mitochondrial dysfunction. Pain. 2006;122:245–257.
- Melli G., Taiana M., Camozzi F., Triolo D., Podini P., Quattrini A., Taroni F., Lauria G. Alpha-lipoic acid prevents mitochondrial damage and neurotoxicity in experimental chemotherapy neuropathy. Exp. Neurol. 2008;214:276–284.
- Giordano S., Darley-Usmar V., Zhang J. Autophagy as an essential cellular antioxidant pathway in neurodegenerative disease. Redox Biol. 2013;2
- Bianchi G., Vitali G., Caraceni A., Ravaglia S., Capri G., Cundari S., Zanna C., Gianni L. Symptomatic and neurophysiological responses of paclitaxel-or cisplatin-induced neuropathy to oral acetyl-L-carnitine. Eur. J. Cancer. 2005;41:1746–1750.
- Gedlicka C., Kornek G.V., Schmid K., Scheithauer W. Amelioration of docetaxel/cisplatin induced polyneuropathy by α-lipoic acid. Ann. Oncol. 2003;14:339–340.
- Schloss J.M., Colosimo M., Airey C., Masci P., Linnane A.W., Vitetta L. Nutraceuticals and chemotherapy induced peripheral neuropathy (CIPN): a systematic review. Clin. Nutr. 2013;32:888–893.
- Kamat C.D., Gadal S., Mhatre M., Williamson K.S., Pye Q.N., Hensley K. Antioxidants in central nervous system diseases: preclinical promise and translational challenges. J. Alzheimers Dis. 2008;15:473–493.
- Cavaletti G., Frigeni B., Lanzani F., Mattavelli L., Susani E., Alberti P., Cortinovis D., Bidoli P. Chemotherapy-induced peripheral neurotoxicity assessment: a critical revision of the currently available tools. Eur. J. Cancer. 2010;46:479–494.
- Jaggi A.S., Singh N. Mechanisms in cancer–chemotherapeutic drugs-induced peripheral neuropathy. Toxicology. 2012;291:1–9.
- Scripture C.D., Figg W.D., Sparreboom A. Peripheral neuropathy induced by paclitaxel: recent insights and future perspectives. Curr. Neuropharmacol. 2006;4:165–172.
- Argyriou A.A., Polychronopoulos P., Iconomou G., Chroni E., Kalofonos H.P. A review on oxaliplatin-induced peripheral nerve damage. Cancer Treat. Rev. 2008;34:368–377.
- Jain K.K. In: Drug-Induced Neurological Disorders. Jain K.K., editor. Hogrefe & Huber; 2001. Drug-induced peripheral neuropathies; pp. 263–294.
- Smith R.A.J., Hartley R.C., Cocheme H.M., Murphy M.P. Mitochondrial pharmacology. Trends Pharmacol. Sci. 2012;33:341–352.
- Smyth J.F., Bowman A., Perren T., Wilkinson P., Prescott R.J., Quinn K.J., Tedeschi M. Glutathione reduces the toxicity and improves quality of life of women diagnosed with ovarian cancer treated with cisplatin: results of a double-blind, randomised trial. Ann. Oncol. 1997;8:569–573.
- Cascinu S., Catalano V., Cordella L., Labianca R., Giordani P., Baldelli A.M., Beretta G.D., Ubiali E., Catalano G. Neuroprotective effect of reduced glutathione on oxaliplatin-based chemotherapy in advanced colorectal cancer: a randomized, double-blind, placebo-controlled trial. J. Clin. Oncol. 2002;20:3478–3483.
- Nahleh Z., Pruemer J., Lafollette J., Sweany S. Melatonin, a promising role in taxane-related neuropathy. Clin. Med. Insights: Oncol. 2010;4:35–41.
- Lin P.-C., Lee M.-Y., Wang W.-S., Yen C.-C., Chao T.-C., Hsiao L.-T., Yang M.-H., Chen P.-M., Lin K.-P., Chiou T.-J. N-acetylcysteine has neuroprotective effects against oxaliplatin-based adjuvant chemotherapy in colon cancer patients: preliminary data. Support. Care Cancer. 2006;14:484–487.
- Ghoreishi Z., Esfahani A., Djazayeri A., Djalali M., Golestan B., Ayromlou H., Hashemzade S., Jafarabadi M.A., Montazeri V., Keshavarz S.A. Omega-3 fatty acids are protective against paclitaxel-induced peripheral neuropathy: a randomized double-blind placebo controlled trial. BMC Cancer. 2012;12:1–8.
- Wang W.-S., Lin J.-K., Lin T.-C., Chen W.-S., Jiang J.-K., Wang H.-S., Chiou T.-J., Liu J.-H., Yen C.-C., Chen P.-M. Oral glutamine is effective for preventing oxaliplatin-induced neuropathy in colorectal cancer patients. Oncologist. 2007;12:312–319.
- Visovsky C., Collins M., Abbott L., Aschenbrenner J., Hart C. Putting evidence into practice: evidence-based interventions for chemotherapy-induced peripheral neuropathy. Clin. J. Oncol. Nurs. 2007;11:901–913.
- Kottschade L.A., Sloan J.A., Mazurczak M.A., Johnson D.B., Murphy B.P., Rowland K.M., Smith D.A., Berg A.R., Stella P.J., Loprinzi C.L. The use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase III clinical trial. Support. Care Cancer. 2011;19:1769–1777.
- Pace A., Savarese A., Picardo M., Maresca V., Pacetti U., Del Monte G., Biroccio A., Leonetti C., Jandolo B., Cognetti F. Neuroprotective effect of vitamin E supplementation in patients treated with cisplatin chemotherapy. J. Clin. Oncol. 2003;21:927–931.
- Pace A., Giannarelli D., Galia E., Savarese A., Carpano S., Della Giulia M., Pozzi A., Silvani A., Gaviani P., Scaioli V. Vitamin E neuroprotection for cisplatin neuropathy A randomized, placebo-controlled trial. Neurology. 2010;74:762–766.
Source: PubMed